Literature DB >> 31864556

Drastic Response of Rechallenge of Nivolumab in a Patient with NSCLC Who Progressed on the First Nivolumab Treatment.

Satoshi Hirano1, Nami Hayama2, Hiroshi Tabeta3, Tsuguko Kuroki2, Yuka Shiraishi2, Tetsuo Fujita2, Hiroyuki Amano2, Makoto Nakamura2, Shinichiro Shimizu4, Sukeyuki Nakamura2.   

Abstract

Entities:  

Year:  2020        PMID: 31864556     DOI: 10.1016/j.jtho.2019.10.012

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  1 in total

1.  Complete response of squamous cell carcinoma of the lung following treatment with pembrolizumab in an elderly patient: A case report.

Authors:  Eiji Takeuchi; Yuri Okamoto; Naoki Takahashi; Shun Morizumi; Yuko Toyoda; Naoto Kuroda; Kenji Yorita
Journal:  Thorac Cancer       Date:  2020-11-10       Impact factor: 3.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.